Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TUSEB-Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)

NCT04708912 is registered in ClinicalTrials.gov with Başakşehir Çam & Sakura City Hospital as lead sponsor.

NCT NCT04708912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TUSEB-Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
Lead sponsor
Başakşehir Çam & Sakura City Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2020
Completion date
April 1, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19